Press release

Press release

May 10, 2021

Follicum appoints Jonas Edelswärd as new CFO

Follicum AB today announces that Jonas Edelswärd has been appointed as new CFO. He succeeds Fredrik Werner, who has decided to leave his position after 2 years in the company. Jonas Edelswärd will take up his position on 10 May. Jonas Edelswärd, with a MSc in Economics has more than 20 years of experience from […]

March 25, 2021

Follicum appoints new CEO and establishes new role as Chief Scientific Officer

Follicum AB announces today that the company has recruited Dr. Kim Arvid Nielsen as new CEO, taking office on April 6, 2021. He has extensive experience in business development, investor relations and drug development from leading positions in both small and large pharmaceutical companies. At the same time, Follicum is establishing a new position as […]

March 23, 2021

New preclincial study confirms mechanism of action of Follicum’s novel tissue repair peptides

Follicum AB today announces that significant progress has been made in the company’s development of new drug treatments for diabetes and other diseases. Within the framework of a preclinical research project, the interaction between one of Follicum’s tissue-repairing peptide families and a specific receptor has been characterized in detail. This will help accelerate continued optimization […]

October 29, 2020

Follicum carries out a directed share issue of approximately SEK 36.6 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER […]